Brief: Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition
19/06/2026 03:55
BRIEF-Aurobindo Pharma Obtains US FTC Approval For Lannett Acquisition June 19 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - UNIT TO BUY 100% OF LANNETT COMPANY
AUROBINDO PHARMA - OBTAINS US FTC APPROVAL FOR LANNETT ACQUISITION
AUROBINDO PHARMA - EXPECTS LANNETT DEAL TO CLOSE BEFORE END OF JUNE 2026
Source text: ID:nBSE51F0Jx
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11